The Bangladesh Risk of Acute Vascular Events (BRAVE) study: Objectives and design

European Journal of Epidemiology

Volumn 30, Issue 7, 2015, Pages 577-587

  Chowdhury, Rajiv ^a   Alam, Dewan S ^b   Fakir, Ismail Ibrahim ^b   Adnan, Sheikh Daud ^c   Naheed, Aliya ^b   Tasmin, Ishrat ^b   Monower, Md Mostafa ^b   Hossain, Farzana ^b   Hossain, Fatema Mahjabin ^b   Rahman, Md Mostafizur ^b   Afrin, Sadia ^b   Roy, Anjan Kumar ^b   Akter, Minara ^b   Sume, Sima Akter ^b   Biswas, Ajoy Kumer ^b   Pennells, Lisa ^a   Surendran, Praveen ^a   Young, Robin D ^a   Spackman, Sarah A ^a   Hasan, Khaled ^b   Harshfield, Eric ^a   Sheikh, Nasir ^a   Houghton, Richard ^a   Saleheen, Danish ^a,d   Howson, Joanna M M ^a   Butterworth, Adam S ^a   Raqib, Rubhana ^b   Majumder, Abdulla Al Shafi ^c   Danesh, John ^a,e   Di Angelantonio, Emanuele ^a   more..

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

^c National Institute of Cardiovascular Diseases   (Bangladesh)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

Arsenic; Bangladesh; BRAVE; Cardiovascular disease; Coronary heart disease; Genetics; Myocardial infarction; Non communicable diseases; Risk factors; South Asia

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; TROPONIN I;

ADULT; ANTHROPOMETRY; ARTICLE; BANGLADESHI; CASE CONTROL STUDY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DEMOGRAPHY; DIABETES MELLITUS; DNA EXTRACTION; ELECTROCARDIOGRAM; ENVIRONMENTAL FACTOR; ETHNIC DIFFERENCE; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENOTYPE; HEREDITY; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; RETROSPECTIVE STUDY; SOCIAL STATUS; SOUTH ASIAN; STUDY DESIGN; TOBACCO CONSUMPTION; TRIACYLGLYCEROL BLOOD LEVEL; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BANGLADESH; CORONARY ARTERY DISEASE; ETHNOLOGY; GENETICS; MYOCARDIAL INFARCTION; RISK; RISK FACTOR;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BANGLADESH; CASE-CONTROL STUDIES; CORONARY ARTERY DISEASE; CORONARY DISEASE; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RISK; RISK FACTORS;

EID: 84943361668     PISSN: 03932990     EISSN: 15737284     Source Type: Journal    
DOI: 10.1007/s10654-015-0037-2     Document Type: Article

References (40)

1. World Health Organization Global status report on noncommunicable diseases 2014. World Health Organization; 2015.
2. Reddy KS. Cardiovascular disease in non-Western countries. N Engl J Med. 2004; 350(24): 2438-40.
3. Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation. 2001; 104(22): 2746-53.
4. Leeder S, Raymond S, Greenberg H. A race against time: the challenge of cardiovascular disease in developing countries. New York: The Trustees of Columbia University in the city of New York; 2004.
5. Naghavi M, Wang H, Lozano R, Davis A, Liang X, Zhou M, et al Global, regional, and national levels of age-sex specific all-cause and cause specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014; pii: S0140-6736(14)61682-2.
6. Ebrahim S, Pearce N, Smeeth L, Casas JP, Jaffar S, Piot P. Tackling non-communicable diseases in low-and middle-income countries: is the evidence from high-income countries all we need? PLoS Med. 2013; 10(1): e1001377.
7. World Health Organization. The atlas of heart disease and stroke 2010. http://www. who. int/cardiovascular_diseases/resources/atlas/en/index. html. Accessed 8 April 2015.
8. Bangladesh Bureau of Statistics. http://www. bbs. gov. bd/Home. aspx. Accessed 8 April 2015.
9. Islam AK, Majumder AA. Coronary artery disease in Bangladesh: a review. Indian Heart J. 2013; 65(4): 424-35.
10. World Health Organization. Mortality estimates by cause, age, and sex for the year 2004. http://www. who. int/healthinfo/global_burden_disease/estimates_country/en/. Accessed 8 April 2015.
11. Harding S, Rosato M, Teyhan A. Trends for coronary heart disease and stroke mortality among migrants in England and Wales, 1979-2003: slow declines notable for some groups. Heart. 2008; 94(4): 463-70.
12. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, et al. Third universal definition of myocardial infarction. Eur Heart J. 2012; 33(20): 2551-67.
13. Saleheen D, Zaidi M, Rasheed A, Ahmad U, Hakeem A, Murtaza M, et al. The Pakistan Risk of Myocardial Infarction Study: a resource for the study of genetic, lifestyle and other determinants of myocardial infarction in South Asia. Eur J Epidemiol. 2009; 24(6): 329-38.
14. Ahsan H, Chen Y, Parvez F, Argos M, Hussain AI, Momotaj H, et al. Health Effects of Arsenic Longitudinal Study (HEALS): description of a multidisciplinary epidemiologic investigation. J Expo Sci Environ Epidemiol. 2006; 16(2): 191-205.
15. LGC Genomics. Kleargene silica method. http://www. lgcgroup. com/products/dna-extraction-kits/kleargene-silica/#. VH8sStKs VBk. Accessed 8 April 2015.
16. Voight BF, Kang HM, Ding J, Palmer CD, Sidore C, Chines PS, et al. The metabochip, a custom genotyping array for genetic studies of metabolic, cardiovascular, and anthropometric traits. PLoS Genet. 2012; 8(8): e1002793.
17. Exome Chip Design. http://genome. sph. umich. edu/wiki/Exome_Chip_Design. Accessed 8 April 2015.
18. Stroh A. Determination of Pb and Cd in whole blood using isotope dilution ICP-MS. Atom Spectrosc. 1993; 37: 1575-9.
19. Fibrinogen Studies Collaboration, Wood AM, White I, Thompson SG, Lewington S, Danesh J. Regression dilution methods for meta-analysis: assessing long-term variability in plasma fibrinogen among 27, 247 adults in 15 prospective studies. Int J Epidemiol. 2006; 35(6): 1570-8.
20. CARDIoGRAMplusC4D Consortium, Deloukas P, Kanoni S, Willenborg C, Farrall M, Assimes TL, et al. Large-scale association analysis identifies new risk loci for coronary artery disease. Nat Genet. 2013; 45(1): 25-33.
21. 1000 Genomes ProjectConsortium, AbecasisGR, AltshulerD, Auton A, Brooks LD, Durbin RM, et al. A map of human genome variation frompopulation-scale sequencing. Nature. 2010; 467(7319): 1061-73.
22. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. STROBE initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007; 370(9596): 1453-7.
23. NCI-NHGRI Working Group on Replication in Association Studies, Chanock SJ, Manolio T, Boehnke M, Boerwinkle E, Hunter DJ, Thomas G, et al. Replicating genotype-phenotype associations. Nature. 2007; 447(7145): 655-60.
24. Parish S, Collins R, Peto R, Youngman L, Barton J, Jayne K, et al. Cigarette smoking, tar yields, and non-fatal myocardial infarction: 14, 000 cases and 32, 000 controls in the United Kingdom. The International Studies of Infarct Survival (ISIS) Collaborators. BMJ. 1995; 311(7003): 471-7.
25. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004; 364(9438): 937-52.
26. Smith AH, Lingas EO, Rahman M. Contamination of drinkingwater by arsenic in Bangladesh: a public health emergency. Bull World Health Organ. 2000; 78(9): 1093-103.
27. Moon K, Guallar E, Navas-Acien A. Arsenic exposure and cardiovascular disease: an updated systematic review. Curr Atheroscler Rep. 2012; 14(6): 542-55.
28. Chen Y, Graziano JH, Parvez F, Liu M, Slavkovich V, Kalra T, et al. Arsenic exposure from drinking water and mortality from cardiovascular disease in Bangladesh: prospective cohort study. BMJ. 2011; 342: d2431.
29. US Environmental Protection Agency. EPA-60018-83-021F, Assessment for inorganic arsenic, Final Report: EPA2001 Contract No.: Fed. Regist 66.
30. Frisbie SH, Ortega R, Maynard DM, Sarkar B. The concentrations of arsenic and other toxic elements in Bangladesh's drinking water. Environ Health Perspect. 2002; 110(11): 1147-53.
31. London Life Sciences Prospective Population Study. http://www. lolipopstudy. org. Accessed 8 April 2015.
32. East London Genes and Health Study. http://public. ukcrn. org. uk/search/StudyDetail. aspx?StudyID=18124. Accessed 8 April 2015.
33. Dhandapany PS, Sadayappan S, Xue Y, Powell GT, Rani DS, Nallari P, et al. A common MYBPC3 (cardiac myosin binding protein C) variant associated with cardiomyopathies in South Asia. Nat Genet. 2009; 41(2): 187-91.
34. Saxena R, Saleheen D, Been LF, Garavito ML, Braun T, Bjonnes A, et al. Genome-wide association study identifies a novel locus contributing to type 2 diabetes susceptibility in Sikhs of Punjabi origin from India. Diabetes. 2013; 62(5): 1746-55.
35. IBC 50 K CAD Consortium. Large-scale gene-centric analysis identifies novel variants for coronary artery disease. PLoS Genet. 2011; 7(9): e1002260.
36. Coronary Artery Disease. (C4D) Genetics Consortium. A genome-wide association study in Europeans and South Asians identifies five new loci for coronary artery disease. Nat Genet. 2011; 43(4): 339-44.
37. Kooner JS, Saleheen D, Sim X, Sehmi J, Zhang W, Frossard P, et al. Genome-wide association study in individuals of South Asian ancestry identifies six new type 2 diabetes susceptibility loci. Nat Genet. 2011; 43(10): 984-9.
38. Saxena R, Elbers CC, Guo Y, Peter I, Gaunt TR, Mega JL, et al. Large-scale gene-centric meta-analysis across 39 studies identifies type 2 diabetes loci. Am J Hum Genet. 2012; 90(3): 410-25.
39. Wellcome Trust Case Control Consortium. Genome-wide association study of 14, 000 cases of seven common diseases and 3000 shared controls. Nature. 2007; 447(7145): 661-78.
40. Holliday EG, Maguire JM, Evans TJ, Koblar SA, Jannes J, Sturm JW, et al. Common variants at 6p21. 1 are associated with large artery atherosclerotic stroke. Nat Genet. 2012; 44(10): 1147-51.